FTC sues major pharmacy benefit administrators more than insulin charges The agency brought motion towards Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the checklist cost of daily life-preserving insulin medicine. Listen to the article 10 min This audio is automobile-created. You should https://kethek.com/